| The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies S Gierer, S Bertram, F Kaup, F Wrensch, A Heurich, A Krämer-Kühl, ... Journal of virology 87 (10), 5502-5511, 2013 | 404 | 2013 |
| IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms F Wrensch, M Winkler, S Pöhlmann Viruses 6 (9), 3683-3698, 2014 | 152* | 2014 |
| Liver disease and coronavirus disease 2019: from pathogenesis to clinical care A Saviano, F Wrensch, MG Ghany, TF Baumert Hepatology 74 (2), 1088-1100, 2021 | 93 | 2021 |
| Hepatitis C virus and hepatocellular carcinoma: when the host loses its grip K Goto, AA Roca Suarez, F Wrensch, TF Baumert, J Lupberger International journal of molecular sciences 21 (9), 3057, 2020 | 80 | 2020 |
| Interferon-Induced transmembrane protein–mediated inhibition of host cell entry of Ebolaviruses F Wrensch, CB Karsten, K Gnirß, M Hoffmann, K Lu, A Takada, M Winkler, ... The Journal of infectious diseases 212 (suppl_2), S210-S218, 2015 | 79 | 2015 |
| Analysis of Ebola virus entry into macrophages F Dahlmann, N Biedenkopf, A Babler, W Jahnen-Dechent, CB Karsten, ... The Journal of infectious diseases 212 (suppl_2), S247-S257, 2015 | 76 | 2015 |
| Influenza A virus encoding secreted Gaussia luciferase as useful tool to analyze viral replication and its inhibition by antiviral compounds and cellular proteins N Eckert, F Wrensch, S Gärtner, N Palanisamy, U Goedecke, N Jäger, ... PloS one 9 (5), e97695, 2014 | 67 | 2014 |
| Hepatitis C virus (HCV)–apolipoprotein interactions and immune evasion and their impact on HCV vaccine design F Wrensch, E Crouchet, G Ligat, MB Zeisel, ZY Keck, SKH Foung, ... Frontiers in immunology 9, 1436, 2018 | 53 | 2018 |
| Host-targeting therapies for hepatitis C virus infection: current developments and future applications E Crouchet, F Wrensch, C Schuster, MB Zeisel, TF Baumert Therapeutic advances in gastroenterology 11, 1756284818759483, 2018 | 46 | 2018 |
| The innate antiviral response in animals: an evolutionary perspective from flagellates to humans K Majzoub, F Wrensch, TF Baumert Viruses 11 (8), 758, 2019 | 43 | 2019 |
| The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells X Zhuang, S Tsukuda, F Wrensch, PAC Wing, M Schilling, JM Harris, ... IScience 24 (10), 2021 | 41 | 2021 |
| Mapping determinants of virus neutralization and viral escape for rational design of a hepatitis C virus vaccine ML Keck, F Wrensch, BG Pierce, TF Baumert, SKH Foung Frontiers in immunology 9, 1194, 2018 | 40 | 2018 |
| The hemagglutinin of bat-associated influenza viruses is activated by TMPRSS2 for pH-dependent entry into bat but not human cells M Hoffmann, N Krüger, P Zmora, F Wrensch, G Herrler, S Pöhlmann PloS one 11 (3), e0152134, 2016 | 30 | 2016 |
| Interferon‐Induced Transmembrane Proteins Mediate Viral Evasion in Acute and Chronic Hepatitis C Virus Infection F Wrensch, G Ligat, L Heydmann, C Schuster, MB Zeisel, P Pessaux, ... Hepatology 70 (5), 1506-1520, 2019 | 24 | 2019 |
| Analysis of IFITM-IFITM interactions by a flow cytometry-based FRET assay M Winkler, F Wrensch, P Bosch, M Knoth, M Schindler, S Gärtner, ... International journal of molecular sciences 20 (16), 3859, 2019 | 20 | 2019 |
| Comparative analysis of host cell entry of Ebola virus from Sierra Leone, 2014, and Zaire, 1976 H Hofmann-Winkler, K Gnirß, F Wrensch, S Pöhlmann The Journal of infectious diseases 212 (suppl_2), S172-S180, 2015 | 15 | 2015 |
| Virion background and efficiency of virion incorporation determine susceptibility of simian immunodeficiency virus env-driven viral entry to inhibition by IFITM proteins F Wrensch, M Hoffmann, S Gärtner, I Nehlmeier, M Winkler, S Pöhlmann Journal of Virology 91 (2), 10.1128/jvi. 01488-16, 2017 | 12 | 2017 |
| Repertoire and neutralizing activity of antibodies against hepatitis C virus E2 peptide in patients with spontaneous resolution of hepatitis C A Olbrich, H Wardemann, S Böhm, K Rother, CC Colpitts, F Wrensch, ... The Journal of infectious diseases 220 (7), 1209-1218, 2019 | 11 | 2019 |
| Learning from a clinical cohort for HCV vaccine development F Wrensch, Z Keck, SKH Foung, TF Baumert Journal of hepatology 71 (1), 9-11, 2019 | 5 | 2019 |
| In vivo combination of human anti-envelope glycoprotein E2 and-Claudin-1 monoclonal antibodies for prevention of hepatitis C virus infection L Mailly, F Wrensch, L Heydmann, C Fauvelle, N Brignon, MB Zeisel, ... Antiviral research 162, 136-141, 2019 | 5 | 2019 |
Thomas BaumertInserm在 unistra.fr 的电子邮件经过验证
